UngTerapi ApS
Credit rating
Company information
About UngTerapi ApS
UngTerapi ApS (CVR number: 38749463) is a company from KØBENHAVN. The company recorded a gross profit of 3320.9 kDKK in 2023. The operating profit was -188.2 kDKK, while net earnings were -89.2 kDKK. The profitability of the company measured by Return on Assets (ROA) was -6.2 %, which can be considered poor and Return on Equity (ROE) was -11.6 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 20.5 %, a level that can be considered to be low. This means a higher proportion of debt in its capital structure, indicating a greater reliance on borrowed funds. UngTerapi ApS's liquidity measured by quick ratio was 1.2 which is at a high level. Thus, the company is in a strong financial position, with liquid assets surpassing current liabilities. It is well-prepared to cover short-term financial obligations.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Volume | |||||
Net sales | |||||
Gross profit | 1 889.19 | 1 775.47 | 2 285.48 | 3 909.02 | 3 320.91 |
EBIT | 517.06 | 537.22 | 693.12 | 874.84 | - 188.18 |
Net earnings | 402.93 | 429.99 | 611.46 | 724.26 | -89.24 |
Shareholders equity total | 490.59 | 525.58 | 1 137.04 | 1 261.30 | 272.06 |
Balance sheet total (assets) | 1 072.48 | 1 258.20 | 1 779.24 | 2 253.07 | 1 325.30 |
Net debt | - 358.45 | - 707.87 | -37.34 | 56.42 | 402.12 |
Profitability | |||||
EBIT-% | |||||
ROA | 52.1 % | 47.5 % | 51.8 % | 46.3 % | -6.2 % |
ROE | 82.4 % | 84.6 % | 73.6 % | 60.4 % | -11.6 % |
ROI | 98.0 % | 101.4 % | 91.9 % | 74.7 % | -11.0 % |
Economic value added (EVA) | 412.17 | 413.99 | 552.50 | 627.09 | - 211.52 |
Solvency | |||||
Equity ratio | 50.0 % | 46.1 % | 63.9 % | 56.5 % | 20.5 % |
Gearing | 3.5 % | 3.2 % | 1.6 % | 5.9 % | 151.9 % |
Relative net indebtedness % | |||||
Liquidity | |||||
Quick ratio | 1.6 | 1.5 | 2.7 | 2.3 | 1.2 |
Current ratio | 1.3 | 1.3 | 2.7 | 2.2 | 1.2 |
Cash and cash equivalents | 375.42 | 724.84 | 56.01 | 18.31 | 11.03 |
Capital use efficiency | |||||
Trade debtors turnover (days) | |||||
Net working capital % | |||||
Credit risk | |||||
Credit rating | BBB | BBB | BBB | BBB | BB |
Variable visualization
Roles
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.